Synthesis of Potential Agents to Combat the Neglected Tropical Disease Leishmaniasis
Date
2020-11
Contributor
Advisor
Department
Instructor
Depositor
Speaker
Researcher
Consultant
Interviewer
Narrator
Transcriber
Annotator
Journal Title
Journal ISSN
Volume Title
Publisher
University of Hawaiʻi — West Oʻahu
Volume
Number/Issue
Starting Page
Ending Page
Alternative Title
Abstract
Leishmaniasis is an ongoing endemic that affects the lives of millions in Asia, Africa, the Americas, and the Mediterranean. Leishmaniasis is notoriously labeled as both the second-largest parasitic killer and one of thirteen neglected tropical diseases. It is estimated that there are 70,000 deaths and 1.3 million new cases per year. Leishmaniasis is engendered by intracellular parasites that belong to the genus leishmania. These parasites are transmitted via the bite of a group of sand flies. Once infected, Leishmaniasis is manifested in one of three ways: cutaneous, mucocutaneous, and visceral. Symptoms are dependent on the specific form of leishmaniasis contracted. Symptoms can vary from skin lesions, cutaneous/mucosal ulcers, spleno- and hepatomegaly, and organ failure. Currently, there remains no vaccine and contemporary treatments have adverse side effects or are too expensive. Considering that many of these endemic countries are impoverished, it is vital that an innocuous and affordable alternative is found. Recent literature has ascertained the antiparasitic properties of the classification of molecules known as chalcones. This research seeks to synthesize various chalcones for future analysis for anti-leishmanial properties.
Description
A student presentation to the Fall 2020 Student Research and Creative Works Symposium
Keywords
Citation
Extent
1 page
Format
Geographic Location
Time Period
Related To
Related To (URI)
Table of Contents
Rights
Attribution-NonCommercial-NoDerivs 3.0 United States
Rights Holder
Local Contexts
Collections
Email libraryada-l@lists.hawaii.edu if you need this content in ADA-compliant format.